Mar 28 |
Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference
|
Mar 14 |
Heron Therapeutics Full Year 2023 Earnings: Beats Expectations
|
Mar 13 |
Heron Therapeutics, Inc. (NASDAQ:HRTX) Q4 2023 Earnings Call Transcript
|
Mar 13 |
Q4 2023 Heron Therapeutics Inc Earnings Call
|
Mar 13 |
Heron Therapeutics, Inc. 2023 Q4 - Results - Earnings Call Presentation
|
Mar 13 |
Heron Therapeutics, Inc. (HRTX) Q4 2023 Earnings Call Transcript
|
Mar 12 |
Compared to Estimates, Heron Therapeutics (HRTX) Q4 Earnings: A Look at Key Metrics
|
Mar 12 |
Heron Therapeutics Inc (HRTX) Exceeds Full-Year Revenue Guidance for 2023
|
Mar 12 |
Heron Therapeutics GAAP EPS of -$0.07 beats by $0.09, revenue of $34.22M beats by $3M
|
Mar 12 |
Heron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Updates
|